English

SIRNA THERAPEUTICS INC

EDGAR

Quarterly report (10-Q) · filed 2006-11-14

54 filing records in this dataset, filed from 1996-05-15 to 2006-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.96 million USD

2006-09-30 · USD

Exact inputs and evidence

Revenue: 1955000 USD Source

Operating margin

-548.54%

2006-09-30 · %

Exact inputs and evidence

Operating Income: -10724000 USD Source
Revenue: 1955000 USD Source

Operating cash flow

-8.86 million USD

2006-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -17019000 USD Source
Operating Cash Flow: -8164000 USD Source

Free cash flow

-9.76 million USD

2006-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -17019000 USD Source
Operating Cash Flow: -8164000 USD Source
Capital Expenditure: 2569000 USD Source
Capital Expenditure: 1664000 USD Source

Cash and cash equivalents: 28.9 million USD 2006-09-30 Source
Exact value

28892000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.24 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Revenue: 4898000 USD · 2005-01-01 – 2005-12-31 Source
Revenue: 3887000 USD · 2005-01-01 – 2005-09-30 Source
Revenue: 426000 USD · 2006-01-01 – 2006-03-31 Source
Revenue: 852000 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 1955000 USD · 2006-07-01 – 2006-09-30 Source

Net income

-33.4 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Net income: -23917000 USD · 2005-01-01 – 2005-12-31 Source
Net income: -18142000 USD · 2005-01-01 – 2005-09-30 Source
Net income: -7978000 USD · 2006-01-01 – 2006-03-31 Source
Net income: -10074000 USD · 2006-04-01 – 2006-06-30 Source
Net income: -9556000 USD · 2006-07-01 – 2006-09-30 Source

Operating cash flow

-15.2 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Operating cash flow: -13965000 USD · 2005-01-01 – 2005-12-31 Source
Operating cash flow: -15783000 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -6829000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -8164000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -6829000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -17019000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -8164000 USD · 2006-01-01 – 2006-06-30 Source

Capital expenditure

2.76 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Capital expenditure: 604000 USD · 2005-01-01 – 2005-12-31 Source
Capital expenditure: 412000 USD · 2005-01-01 – 2005-09-30 Source
Capital expenditure: 520000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 1664000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 520000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 2569000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 1664000 USD · 2006-01-01 – 2006-06-30 Source

Free cash flow

-18 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Operating cash flow: -13965000 USD · 2005-01-01 – 2005-12-31 Source
Operating cash flow: -15783000 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -6829000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -8164000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -6829000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -17019000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -8164000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 604000 USD · 2005-01-01 – 2005-12-31 Source
Capital expenditure: 412000 USD · 2005-01-01 – 2005-09-30 Source
Capital expenditure: 520000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 1664000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 520000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 2569000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 1664000 USD · 2006-01-01 – 2006-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2006-11-14.

Financial data available through: 2005-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2005-12-31
Operating income: 10 of 11 periods available· newest 2005-12-31
Net income: 11 of 11 periods available· newest 2005-12-31
Operating cash flow: 11 of 11 periods available· newest 2005-12-31
Capital expenditure: 11 of 11 periods available· newest 2005-12-31
Total assets: 10 of 11 periods available· newest 2004-12-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2005-12-31
Current liabilities: 11 of 11 periods available· newest 2005-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2005-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+216.6%

Prior period

USD 1.55 million

2004-01-01 – 2004-12-31
Current period

USD 4.9 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

4898000 − 1547000 = 3351000 USD

1547000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
4898000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Year-over-year change in Revenue: 3351000 USD Concept: fundies:Revenue Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4898000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#13406 Input fundies:Revenue: 1547000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#13406
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.94 million

Prior period

−USD 28.86 million

2004-01-01 – 2004-12-31
Current period

−USD 23.92 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

-23917000 − -28857000 = 4940000 USD

-28857000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
-23917000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Year-over-year change in Net income: 4940000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -23917000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#20898 Input fundies:NetIncome: -28857000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#20898
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 8.91 million

Prior period

−USD 22.87 million

2004-01-01 – 2004-12-31
Current period

−USD 13.97 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

-13965000 − -22871000 = 8906000 USD

-22871000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
-13965000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Year-over-year change in Operating cash flow: 8906000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13965000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008 Input fundies:OperatingCashFlow: -22871000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+52.1%

Prior period

USD 397,000

2004-01-01 – 2004-12-31
Current period

USD 604,000

2005-01-01 – 2005-12-31

Exact inputs and evidence

604000 − 397000 = 207000 USD

397000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
604000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Year-over-year change in Capital expenditure: 207000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 604000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229 Input fundies:CapitalExpenditure: 397000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2005 2005-01-01 – 2005-12-31

Revenue USD 4.9 million 100% of revenue
Operating costs Derived USD 29.88 million 610% of revenue
Operating income −USD 24.98 million −510% of revenue
Tax, interest and other Derived −USD 1.06 million −22% of revenue
Net income −USD 23.92 million −488% of revenue

Cash

Operating cash flow −USD 13.97 million −285% of revenue
Capital expenditure USD 604,000 12% of revenue
Free cash flow Derived −USD 14.57 million −297% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Operating loss: operating costs were 2,087% of revenue.
1997 Operating loss: operating costs were 860% of revenue.
1998 Operating loss: operating costs were 209% of revenue.
1999 Operating loss: operating costs were 229% of revenue.
2000 Operating loss: operating costs were 164% of revenue.
2001 Operating loss: operating costs were 737% of revenue.
2002 Operating loss: operating costs were 664% of revenue.
2003 Operating loss: operating costs were 810% of revenue.
2004 Operating loss: operating costs were 1,975% of revenue.
2005 Operating loss: operating costs were 610% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	773103	16132419 Derived	-15359316	-91736 Derived	-15267580	-14159195 Derived	Source 1996-01-01 – 1996-12-31: 773103 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -15359316 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -15267580 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -12617783 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 1541412 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	1983142	17055839 Derived	-15072697	49397 Derived	-15122094	-14876406 Derived	Source 1997-01-01 – 1997-12-31: 1983142 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -15072697 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -15122094 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -12663095 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 2213311 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	8987858	18754512 Derived	-9766654	1150913 Derived	-10917567	-10066410 Derived	Source 1998-01-01 – 1998-12-31: 8987858 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -9766654 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -10917567 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -9130015 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 936395 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	7664398	17526854 Derived	-9862456	798125 Derived	-10660581	-6496149 Derived	Source 1999-01-01 – 1999-12-31: 7664398 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -9862456 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -10660581 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -5370295 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1125854 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	15545312	25444213 Derived	-9898901	5982656 Derived	-15881557	-4922437 Derived	Source 2000-01-01 – 2000-12-31: 15545312 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -9898901 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -15881557 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -3533780 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 1388657 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	8308000	61201000 Derived	-52893000	6945000 Derived	-59838000	-47552000 Derived	Source 2001-01-01 – 2001-12-31: 8308000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -52893000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -59838000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -44729000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 2823000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	5148000	34164000 Derived	-29016000	5690000 Derived	-34706000	-24041000 Derived	Source 2002-01-01 – 2002-12-31: 5148000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -29016000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -34706000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -22402000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1639000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	4175000	33809000 Derived	-29634000	207000 Derived	-29841000	-21112000 Derived	Source 2003-01-01 – 2003-12-31: 4175000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -29634000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -29841000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -20772000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 340000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	1547000	30552000 Derived	-29005000	-148000 Derived	-28857000	-23268000 Derived	Source 2004-01-01 – 2004-12-31: 1547000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -29005000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -28857000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -22871000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 397000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	4898000	29877000 Derived	-24979000	-1062000 Derived	-23917000	-14569000 Derived	Source 2005-01-01 – 2005-12-31: 4898000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -24979000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -23917000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -13965000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 604000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.9M 2005

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	773103	Revenue: 773103 Open source
19971997-12-31	Revenue	1983142	Revenue: 1983142 Open source
19981998-12-31	Revenue	8987858	Revenue: 8987858 Open source
19991999-12-31	Revenue	7664398	Revenue: 7664398 Open source
20002000-12-31	Revenue	15545312	Revenue: 15545312 Open source
20012001-12-31	Revenue	8308000	Revenue: 8308000 Open source
20022002-12-31	Revenue	5148000	Revenue: 5148000 Open source
20032003-12-31	Revenue	4175000	Revenue: 4175000 Open source
20042004-12-31	Revenue	1547000	Revenue: 1547000 Open source
20052005-12-31	Revenue	4898000	Revenue: 4898000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

216.6% 2005

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	-53.8%	Revenue: 773103 Open source Revenue: 1674880 Open source
19971997-12-31	Year over year	156.5%	Revenue: 1983142 Open source Revenue: 773103 Open source
19981998-12-31	Year over year	353.2%	Revenue: 8987858 Open source Revenue: 1983142 Open source
19991999-12-31	Year over year	-14.7%	Revenue: 7664398 Open source Revenue: 8987858 Open source
20002000-12-31	Year over year	102.8%	Revenue: 15545312 Open source Revenue: 7664398 Open source
20012001-12-31	Year over year	-46.6%	Revenue: 8308000 Open source Revenue: 15545312 Open source
20022002-12-31	Year over year	-38%	Revenue: 5148000 Open source Revenue: 8308000 Open source
20032003-12-31	Year over year	-18.9%	Revenue: 4175000 Open source Revenue: 5148000 Open source
20042004-12-31	Year over year	-62.9%	Revenue: 1547000 Open source Revenue: 4175000 Open source
20052005-12-31	Year over year	216.6%	Revenue: 4898000 Open source Revenue: 1547000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -510% 2005

Net margin -488.3% 2005

Free cash flow margin -297.4% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Operating margin	-1,986.7%	Operating Income: -15359316 Open source Revenue: 773103 Open source
19971997-12-31	Operating margin	-760%	Operating Income: -15072697 Open source Revenue: 1983142 Open source
19981998-12-31	Operating margin	-108.7%	Operating Income: -9766654 Open source Revenue: 8987858 Open source
19991999-12-31	Operating margin	-128.7%	Operating Income: -9862456 Open source Revenue: 7664398 Open source
20002000-12-31	Operating margin	-63.7%	Operating Income: -9898901 Open source Revenue: 15545312 Open source
20012001-12-31	Operating margin	-636.7%	Operating Income: -52893000 Open source Revenue: 8308000 Open source
20022002-12-31	Operating margin	-563.6%	Operating Income: -29016000 Open source Revenue: 5148000 Open source
20032003-12-31	Operating margin	-709.8%	Operating Income: -29634000 Open source Revenue: 4175000 Open source
20042004-12-31	Operating margin	-1,874.9%	Operating Income: -29005000 Open source Revenue: 1547000 Open source
20052005-12-31	Operating margin	-510%	Operating Income: -24979000 Open source Revenue: 4898000 Open source
19961996-12-31	Net margin	-1,974.8%	Net Income: -15267580 Open source Revenue: 773103 Open source
19971997-12-31	Net margin	-762.5%	Net Income: -15122094 Open source Revenue: 1983142 Open source
19981998-12-31	Net margin	-121.5%	Net Income: -10917567 Open source Revenue: 8987858 Open source
19991999-12-31	Net margin	-139.1%	Net Income: -10660581 Open source Revenue: 7664398 Open source
20002000-12-31	Net margin	-102.2%	Net Income: -15881557 Open source Revenue: 15545312 Open source
20012001-12-31	Net margin	-720.2%	Net Income: -59838000 Open source Revenue: 8308000 Open source
20022002-12-31	Net margin	-674.2%	Net Income: -34706000 Open source Revenue: 5148000 Open source
20032003-12-31	Net margin	-714.8%	Net Income: -29841000 Open source Revenue: 4175000 Open source
20042004-12-31	Net margin	-1,865.4%	Net Income: -28857000 Open source Revenue: 1547000 Open source
20052005-12-31	Net margin	-488.3%	Net Income: -23917000 Open source Revenue: 4898000 Open source
19961996-12-31	Free cash flow margin	-1,831.5%	Revenue: 773103 Open source Operating Cash Flow: -12617783 Open source Capital Expenditure: 1541412 Open source
19971997-12-31	Free cash flow margin	-750.1%	Revenue: 1983142 Open source Operating Cash Flow: -12663095 Open source Capital Expenditure: 2213311 Open source
19981998-12-31	Free cash flow margin	-112%	Revenue: 8987858 Open source Operating Cash Flow: -9130015 Open source Capital Expenditure: 936395 Open source
19991999-12-31	Free cash flow margin	-84.8%	Revenue: 7664398 Open source Operating Cash Flow: -5370295 Open source Capital Expenditure: 1125854 Open source
20002000-12-31	Free cash flow margin	-31.7%	Revenue: 15545312 Open source Operating Cash Flow: -3533780 Open source Capital Expenditure: 1388657 Open source
20012001-12-31	Free cash flow margin	-572.4%	Revenue: 8308000 Open source Operating Cash Flow: -44729000 Open source Capital Expenditure: 2823000 Open source
20022002-12-31	Free cash flow margin	-467%	Revenue: 5148000 Open source Operating Cash Flow: -22402000 Open source Capital Expenditure: 1639000 Open source
20032003-12-31	Free cash flow margin	-505.7%	Revenue: 4175000 Open source Operating Cash Flow: -20772000 Open source Capital Expenditure: 340000 Open source
20042004-12-31	Free cash flow margin	-1,504.1%	Revenue: 1547000 Open source Operating Cash Flow: -22871000 Open source Capital Expenditure: 397000 Open source
20052005-12-31	Free cash flow margin	-297.4%	Revenue: 4898000 Open source Operating Cash Flow: -13965000 Open source Capital Expenditure: 604000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	-12617783	Operating Cash Flow: -12617783 Open source
19971997-12-31	Operating cash flow	-12663095	Operating Cash Flow: -12663095 Open source
19981998-12-31	Operating cash flow	-9130015	Operating Cash Flow: -9130015 Open source
19991999-12-31	Operating cash flow	-5370295	Operating Cash Flow: -5370295 Open source
20002000-12-31	Operating cash flow	-3533780	Operating Cash Flow: -3533780 Open source
20012001-12-31	Operating cash flow	-44729000	Operating Cash Flow: -44729000 Open source
20022002-12-31	Operating cash flow	-22402000	Operating Cash Flow: -22402000 Open source
20032003-12-31	Operating cash flow	-20772000	Operating Cash Flow: -20772000 Open source
20042004-12-31	Operating cash flow	-22871000	Operating Cash Flow: -22871000 Open source
20052005-12-31	Operating cash flow	-13965000	Operating Cash Flow: -13965000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.6M 2005

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	-14159195	Operating Cash Flow: -12617783 Open source Capital Expenditure: 1541412 Open source
19971997-12-31	Free cash flow	-14876406	Operating Cash Flow: -12663095 Open source Capital Expenditure: 2213311 Open source
19981998-12-31	Free cash flow	-10066410	Operating Cash Flow: -9130015 Open source Capital Expenditure: 936395 Open source
19991999-12-31	Free cash flow	-6496149	Operating Cash Flow: -5370295 Open source Capital Expenditure: 1125854 Open source
20002000-12-31	Free cash flow	-4922437	Operating Cash Flow: -3533780 Open source Capital Expenditure: 1388657 Open source
20012001-12-31	Free cash flow	-47552000	Operating Cash Flow: -44729000 Open source Capital Expenditure: 2823000 Open source
20022002-12-31	Free cash flow	-24041000	Operating Cash Flow: -22402000 Open source Capital Expenditure: 1639000 Open source
20032003-12-31	Free cash flow	-21112000	Operating Cash Flow: -20772000 Open source Capital Expenditure: 340000 Open source
20042004-12-31	Free cash flow	-23268000	Operating Cash Flow: -22871000 Open source Capital Expenditure: 397000 Open source
20052005-12-31	Free cash flow	-14569000	Operating Cash Flow: -13965000 Open source Capital Expenditure: 604000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Liabilities / assets	Not reported	Total Assets: 25291570 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 24850041 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 19224291 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 25092099 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 83896993 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 52023208 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 21898000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 42684000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 41557000 Open source
2005-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

6.91× 2005

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Current assets / current liabilities	7.33×	Current Assets: 18281961 Open source Current Liabilities: 2493802 Open source
19971997-12-31	Current assets / current liabilities	5.1×	Current Assets: 16465994 Open source Current Liabilities: 3228408 Open source
19981998-12-31	Current assets / current liabilities	5.19×	Current Assets: 10613325 Open source Current Liabilities: 2044836 Open source
19991999-12-31	Current assets / current liabilities	7.4×	Current Assets: 16286545 Open source Current Liabilities: 2200917 Open source
20002000-12-31	Current assets / current liabilities	20.43×	Current Assets: 68348186 Open source Current Liabilities: 3346010 Open source
20012001-12-31	Current assets / current liabilities	7.22×	Current Assets: 37035733 Open source Current Liabilities: 5127436 Open source
20022002-12-31	Current assets / current liabilities	2×	Current Assets: 10060000 Open source Current Liabilities: 5033000 Open source
20032003-12-31	Current assets / current liabilities	9.24×	Current Assets: 37337000 Open source Current Liabilities: 4042000 Open source
20042004-12-31	Current assets / current liabilities	5.4×	Current Assets: 37050000 Open source Current Liabilities: 6855000 Open source
20052005-12-31	Current assets / current liabilities	6.91×	Current Assets: 46276000 Open source Current Liabilities: 6699000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1996-01-01 – 1996-12-31	−USD 15.27 million Exact value Exact value: -15267580 USD 1996-01-01 – 1996-12-31: -15267580 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 1996-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -15267580 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15267580 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-99-000829.txt#3415 The citation records this snapshot. The page link may show a newer release later.	−USD 12.62 million Exact value Exact value: -12617783 USD 1996-01-01 – 1996-12-31: -12617783 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 1996-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -12617783 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12617783 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-99-000829.txt#3439 The citation records this snapshot. The page link may show a newer release later.	USD 1.54 million Exact value Exact value: 1541412 USD 1996-01-01 – 1996-12-31: 1541412 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 1996-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 1541412 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1541412 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-99-000829.txt#3442 The citation records this snapshot. The page link may show a newer release later.	−USD 14.16 million Calculation and evidence -12617783 − 1541412 USD Exact free cash flow: -14159195 USD 1996-01-01 – 1996-12-31: -12617783 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 1541412 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 1996-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -14159195 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12617783 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-99-000829.txt#3439 Input fundies:CapitalExpenditure: 1541412 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-99-000829.txt#3442 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 15.12 million Exact value Exact value: -15122094 USD 1997-01-01 – 1997-12-31: -15122094 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 1997-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -15122094 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15122094 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-00-000347.txt#3163 The citation records this snapshot. The page link may show a newer release later.	−USD 12.66 million Exact value Exact value: -12663095 USD 1997-01-01 – 1997-12-31: -12663095 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 1997-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -12663095 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12663095 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-00-000347.txt#3201 The citation records this snapshot. The page link may show a newer release later.	USD 2.21 million Exact value Exact value: 2213311 USD 1997-01-01 – 1997-12-31: 2213311 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 1997-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 2213311 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2213311 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-00-000347.txt#3204 The citation records this snapshot. The page link may show a newer release later.	−USD 14.88 million Calculation and evidence -12663095 − 2213311 USD Exact free cash flow: -14876406 USD 1997-01-01 – 1997-12-31: -12663095 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 2213311 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 1997-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -14876406 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12663095 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-00-000347.txt#3201 Input fundies:CapitalExpenditure: 2213311 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-00-000347.txt#3204 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 10.92 million Exact value Exact value: -10917567 USD 1998-01-01 – 1998-12-31: -10917567 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 1998-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -10917567 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10917567 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-01-000361.txt#2446 The citation records this snapshot. The page link may show a newer release later.	−USD 9.13 million Exact value Exact value: -9130015 USD 1998-01-01 – 1998-12-31: -9130015 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 1998-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -9130015 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9130015 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-01-000361.txt#2468 The citation records this snapshot. The page link may show a newer release later.	USD 936,395 Exact value Exact value: 936395 USD 1998-01-01 – 1998-12-31: 936395 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 1998-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 936395 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 936395 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-01-000361.txt#2471 The citation records this snapshot. The page link may show a newer release later.	−USD 10.07 million Calculation and evidence -9130015 − 936395 USD Exact free cash flow: -10066410 USD 1998-01-01 – 1998-12-31: -9130015 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 936395 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 1998-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -10066410 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9130015 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-01-000361.txt#2468 Input fundies:CapitalExpenditure: 936395 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000927356-01-000361.txt#2471 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 10.66 million Exact value Exact value: -10660581 USD 1999-01-01 – 1999-12-31: -10660581 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 1999-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -10660581 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10660581 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000930661-03-000509.txt#6891 The citation records this snapshot. The page link may show a newer release later.	−USD 5.37 million Exact value Exact value: -5370295 USD 1999-01-01 – 1999-12-31: -5370295 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 1999-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -5370295 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5370295 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000930661-03-000509.txt#7200 The citation records this snapshot. The page link may show a newer release later.	USD 1.13 million Exact value Exact value: 1125854 USD 1999-01-01 – 1999-12-31: 1125854 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 1999-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 1125854 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1125854 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000930661-03-000509.txt#7228 The citation records this snapshot. The page link may show a newer release later.	−USD 6.5 million Calculation and evidence -5370295 − 1125854 USD Exact free cash flow: -6496149 USD 1999-01-01 – 1999-12-31: -5370295 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1125854 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 1999-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -6496149 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5370295 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000930661-03-000509.txt#7200 Input fundies:CapitalExpenditure: 1125854 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000930661-03-000509.txt#7228 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 15.88 million Exact value Exact value: -15881557 USD 2000-01-01 – 2000-12-31: -15881557 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 2000-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -15881557 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15881557 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001104659-03-005305.txt#15601 The citation records this snapshot. The page link may show a newer release later.	−USD 3.53 million Exact value Exact value: -3533780 USD 2000-01-01 – 2000-12-31: -3533780 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 2000-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -3533780 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3533780 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001104659-03-005305.txt#16202 The citation records this snapshot. The page link may show a newer release later.	USD 1.39 million Exact value Exact value: 1388657 USD 2000-01-01 – 2000-12-31: 1388657 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 2000-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 1388657 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1388657 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001104659-03-005305.txt#16282 The citation records this snapshot. The page link may show a newer release later.	−USD 4.92 million Calculation and evidence -3533780 − 1388657 USD Exact free cash flow: -4922437 USD 2000-01-01 – 2000-12-31: -3533780 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 1388657 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 2000-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -4922437 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3533780 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001104659-03-005305.txt#16202 Input fundies:CapitalExpenditure: 1388657 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001104659-03-005305.txt#16282 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 59.84 million Exact value Exact value: -59838000 USD 2001-01-01 – 2001-12-31: -59838000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 2001-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -59838000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -59838000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-04-044311.txt#7535 The citation records this snapshot. The page link may show a newer release later.	−USD 44.73 million Exact value Exact value: -44729000 USD 2001-01-01 – 2001-12-31: -44729000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 2001-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -44729000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -44729000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-04-044311.txt#7899 The citation records this snapshot. The page link may show a newer release later.	USD 2.82 million Exact value Exact value: 2823000 USD 2001-01-01 – 2001-12-31: 2823000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 2001-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 2823000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2823000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-04-044311.txt#7932 The citation records this snapshot. The page link may show a newer release later.	−USD 47.55 million Calculation and evidence -44729000 − 2823000 USD Exact free cash flow: -47552000 USD 2001-01-01 – 2001-12-31: -44729000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 2823000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 2001-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -47552000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -44729000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-04-044311.txt#7899 Input fundies:CapitalExpenditure: 2823000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-04-044311.txt#7932 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 34.71 million Exact value Exact value: -34706000 USD 2002-01-01 – 2002-12-31: -34706000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 2002-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -34706000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34706000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-05-067267.txt#7477 The citation records this snapshot. The page link may show a newer release later.	−USD 22.4 million Exact value Exact value: -22402000 USD 2002-01-01 – 2002-12-31: -22402000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 2002-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -22402000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22402000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-05-067267.txt#7841 The citation records this snapshot. The page link may show a newer release later.	USD 1.64 million Exact value Exact value: 1639000 USD 2002-01-01 – 2002-12-31: 1639000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 2002-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 1639000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1639000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-05-067267.txt#7874 The citation records this snapshot. The page link may show a newer release later.	−USD 24.04 million Calculation and evidence -22402000 − 1639000 USD Exact free cash flow: -24041000 USD 2002-01-01 – 2002-12-31: -22402000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1639000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 2002-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -24041000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22402000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-05-067267.txt#7841 Input fundies:CapitalExpenditure: 1639000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0001193125-05-067267.txt#7874 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 29.84 million Exact value Exact value: -29841000 USD 2003-01-01 – 2003-12-31: -29841000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 2003-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -29841000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29841000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#20898 The citation records this snapshot. The page link may show a newer release later.	−USD 20.77 million Exact value Exact value: -20772000 USD 2003-01-01 – 2003-12-31: -20772000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 2003-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -20772000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20772000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008 The citation records this snapshot. The page link may show a newer release later.	USD 340,000 Exact value Exact value: 340000 USD 2003-01-01 – 2003-12-31: 340000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 2003-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 340000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 340000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229 The citation records this snapshot. The page link may show a newer release later.	−USD 21.11 million Calculation and evidence -20772000 − 340000 USD Exact free cash flow: -21112000 USD 2003-01-01 – 2003-12-31: -20772000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 340000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 2003-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -21112000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20772000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008 Input fundies:CapitalExpenditure: 340000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 28.86 million Exact value Exact value: -28857000 USD 2004-01-01 – 2004-12-31: -28857000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 2004-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -28857000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28857000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#20898 The citation records this snapshot. The page link may show a newer release later.	−USD 22.87 million Exact value Exact value: -22871000 USD 2004-01-01 – 2004-12-31: -22871000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 2004-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -22871000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22871000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008 The citation records this snapshot. The page link may show a newer release later.	USD 397,000 Exact value Exact value: 397000 USD 2004-01-01 – 2004-12-31: 397000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 2004-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 397000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 397000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229 The citation records this snapshot. The page link may show a newer release later.	−USD 23.27 million Calculation and evidence -22871000 − 397000 USD Exact free cash flow: -23268000 USD 2004-01-01 – 2004-12-31: -22871000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 397000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 2004-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -23268000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22871000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008 Input fundies:CapitalExpenditure: 397000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 23.92 million Exact value Exact value: -23917000 USD 2005-01-01 – 2005-12-31: -23917000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Net Income: -23917000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23917000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#20898 The citation records this snapshot. The page link may show a newer release later.	−USD 13.97 million Exact value Exact value: -13965000 USD 2005-01-01 – 2005-12-31: -13965000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Operating Cash Flow: -13965000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13965000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008 The citation records this snapshot. The page link may show a newer release later.	USD 604,000 Exact value Exact value: 604000 USD 2005-01-01 – 2005-12-31: 604000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Capital Expenditure: 604000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 604000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229 The citation records this snapshot. The page link may show a newer release later.	−USD 14.57 million Calculation and evidence -13965000 − 604000 USD Exact free cash flow: -14569000 USD 2005-01-01 – 2005-12-31: -13965000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 604000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIRNA THERAPEUTICS INC · 2005-12-31 SIRNA THERAPEUTICS INC (edgar:892112) Free cash flow: -14569000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-05T00:37:29Z Snapshot: 1d1130905cf8fce9a2018fabc392b5f62400c061c010ed8fb1521a1fd197d098 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892112?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13965000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22008 Input fundies:CapitalExpenditure: 604000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892112/0000950149-06-000151.txt#22229 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

54 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-05. Source filing dates and reporting periods are shown separately.

Identifiers: 0000892112, 892112, edgar:892112

Also known as RIBOZYME PHARMACEUTICALS INC

SIRNA THERAPEUTICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2005 2005-01-01 – 2005-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation